Family Psychoeducation for Adults With Psychotic Disorders in Tanzania

Not Applicable

Completed

• Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders, Severe
• Interventions: Behavioral: KUPAA Intervention Group (Culturally Tailored Family Psychoeducation)

• Registration Number: NCT04013932
• Lead Sponsor: Duke University

Brief Summary

The goal of this study is to pilot test a culturally tailored Family Psychoeducation model (KUPAA) for adults with psychotic disorders and their relatives that is appropriate for cultural settings inclusive of both traditional and biomedical ideas about mental illness and that incorporates relatives as co-facilitators of the intervention.

Detailed Description

Family psychoeducation (FPE) is an evidence-based practice used in high-income countries to help individuals with psychotic disorders and their relatives to cope more effectively with the illness. FPE has never been tested in a low-resource country nor have the mechanisms of action for this psychosocial intervention been fully identified in any context. The goal of this study is to pilot test a culturally tailored Family Psychoeducation model (called KUPAA) for adults with psychotic disorders and their relatives that is appropriate for cultural settings inclusive of both traditional and biomedical ideas about mental illness and that incorporates relatives as co-facilitators of the intervention. Formative research has already been conducted to culturally tailor the model for the Tanzanian context. This pilot study is a small randomized controlled trial (RCT) with 72 patient/relative dyads that will test the KUPAA intervention to a) assess the feasibility and acceptability of the adapted family psychoeducation intervention for 12 weeks, and b) explore its impact on patient relapse, quality of life and disability.

Primary study objectives

1. To pilot test the KUPAA intervention to explore its impact on patient relapse, quality of life and disability

Secondary study objectives

2. To elucidate the mechanisms of action for KUPAA (e.g. hopefulness, self-efficacy) and refine the mediation and study outcome measures for a future R01/fully powered clinical trial

Study Timeline

• Study First Submitted: 2019-07-08
• Study First Submitted QC: 2019-07-08
• Study First Posted: 2019-07-10
• Study Start: 2019-08-06
• Primary Completion: 2020-10-27
• Study Completion: 2020-10-27
• Results First Submitted: 2021-11-17
• Status Verified: 2022-01
• Results First Submitted QC: 2022-01-07
• Last Update Submitted: 2022-01-07
• Results First Posted: 2022-02-04
• Last Update Posted: 2022-02-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

• Attending outpatient psychiatric services at Muhimbili National Hospital (MNH) or Mbeya Zonal Referral Hospital (MZRH).
• ICD-10 Diagnosis of a non-organic psychotic disorder:
• F20 Schizophrenia
• F21 Schizotypal disorder
• F22 Delusional disorders
• F25 Schizoaffective disorders
• Age 18-50 at the time of informed consent
• Hospitalization or relapse (confirmed by attending psychiatrist or medical officer) within the past 12 months.

Patient

Read More

Exclusion Criteria

• F23 Brief psychotic disorder
• F28 Other psychotic disorder not due to a substance or known physiological condition
• F29 Unspecified psychosis not due to a substance or known physiological condition
• Epileptic psychoses
• Bipolar disorder and mania
• Co-morbid developmental disorder, dementia, or other severe cognitive deficit that renders the individual unable to provided informed consent.

Caregiver Inclusion Criteria:

• Age 18 or older at time of consenting process
• Patient agrees that this person can be their paired partner for KUPAA if the pair is randomized to the intervention group

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
KUPAA Intervention + Standard of Care	KUPAA Intervention Group (Culturally Tailored Family Psychoeducation)	Patients will be assigned to a KUPAA group composed of approximately 6 patients (joined by their 6 matched caregivers). Patients will first participate in 1-2 joining sessions with a provider, followed by a 1-day group educational workshop. Participants will then attend weekly family psychoeducation group sessions (\~1.5-2 hours) for 12 weeks.

Primary Outcome Measures

Name	Time	Method
Proportion of Patient Participants Who Experience Illness Relapse	Relapse is measured from immediate post-intervention to endline (~6-7 months post-intervention)	Patient relapse measured by hospitalization or non-hospitalized relapse, defined as a new illness episode with recurrence of symptoms after one month of controlled symptoms.
Change From Baseline to Endline in Disability, as Measured by the World Health Organization Disability Assessment Schedule Version 2.0 (WHODAS 2.0)	Baseline (pre-intervention) and Endline (~6-7 months post-intervention)	Scores are measured from the 36-item WHODAS 2.0, the World Health Organization Disability Assessment Schedule, which measures health and disability. WHODAS 2.0 This self-report assessment measures difficulties performing daily activities over the past 30 days. It consists of 36 Likert-formatted questions across six domains: understanding and communicating, getting around, self-care, getting along with others, life activities, and participation in society. WHO's guidelines for the complex scoring method were used to create the total score, ranging from 0 (no disability) to 100 (full disability). Higher scores indicate worse outcomes.
Change From Baseline to Endline in Quality of Life, as Measured by the World Health Organization Quality of Life- Abbreviated Version (WHOQOL-BREF)	Baseline (pre-intervention) and Endline (~6-7 months post-intervention)	Raw total scores are measured from the 26-item WHOQOL-BREF (the abbreviated version of the World Health Organization Quality of Life 100 scale). This self-report assessment has 26 questions across four domains; physical health, psychological, social relationships, and environment. Each item is rated on a five-point Likert scale (1-5) ranging from 1 (not at all, very dissatisfied, very poor) to 5 (an extreme amount, very satisfied, very good); three items needed reverse scoring. The range is 26 (min) to 130 (max) for the total raw score. Higher scores indicate a better outcome.

Trial Locations

Locations (2)

Mbeya Zonal Referral Hospital; 🇹🇿 Mbeya, Tanzania

Muhimbili University of Health and Allied Sciences (MUHAS); 🇹🇿 Dar Es Salaam, Tanzania